Cipla Ltd. | CIPLA | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2019
2020
2021
2022
2023
Net Income
Net Income
20,791
21,782
32,901
36,754
42,208
Cash flow Operating Act...
Cash flow Operating Activities
16,91130,68537,55233,25932,377
Investments in PPE
Investments in PPE
-3,601-5,728-8,189-7,012-11,829
Cash flow Investing Act...
Net cash used for Investment Activities
-16,6871,040-23,872-18,719-23,885
Dividend Paid
Dividend Paid
2,8416,64204,0344,035
Cash flow Financing Act...
Net cash provided by Financing Activities
-3,487-29,488-13,299-15,998-9,583
Cash at beginning of period
Cash at beginning of period
8,5355,0847,4247,9046,581
Cash at end of period
Cash at end of period
5,0847,4247,9336,5815,613
Free Cash Flow
Free Cash Flow
13,311
24,957
29,363
26,248
20,548